END USER LICENSE AGREEMENT

This END USER LICENSE AGREEMENT (THE “EULA”) IS BETWEEN CUSTOMER (“CUSTOMER“ OR “YOU”) AND TRAIT TECHNOLOGIES, INC. (THE “COMPANY”) AND GOVERNS YOUR USE OF COMPANY’S SOFTWARE AND SERVICES. IF YOU DO NOT AGREE WITH THESE TERMS AND CONDITIONS, YOU MUST NOT ACCEPT THIS EULA AND MAY NOT USE THE SOFTWARE AND SERVICES. BY ACCEPTING THIS EULA, EITHER BY CLICKING A BOX OR ICON INDICATING YOUR ACCEPTANCE OR BY EXECUTING AN ORDERING DOCUMENT THAT REFERENCES THIS EULA, YOU AGREE TO THE TERMS OF THIS EULA. THIS EULA IS EFFECTIVE BETWEEN CUSTOMER AND COMPANY AS OF THE DATE OF YOU ACCEPTING THIS EULA.

THE MEDTRAIT PLATFORM: SUMMARY

Contingent upon Your agreement to the terms and conditions of this EULA, You will be given access to Company’s MedTrait® platform. The MedTrait® platform is a software solution developed by Company that may:

§ assist medical professionals to manage patient medication regimens by providing pharmacogenetic (“PGx”) reporting and medication management tools designed for precision medicine in healthcare, which help providers personalize a low risk treatment regimen and evaluate better alternatives in real time. Specifically, MedTrait® is a PGx-assisted precision medicine reporting platform and real time medication management tool which allows a healthcare providers analyze whole-patient prescribing complexities and be alerted to complications, allowing them to reduce risk of dangerous interactions proactively.

Company reserves the right to alter the characteristics, specifications, and functionality of the MedTrait ®platform at any time.

HOW WE USE YOUR DATA: SUMMARY

In order to use the Company’s Software and Services, You and/or Your Authorized Users will be required to provide certain Personal Data, such as a name, email, address, Access Credentials and other personally identifiable information.

In order to ensure that you understand how any Data collected in connection with your use of the Software and Services, provided below is an explanation of the different ways we may use this Data.

§ Company collects, generates, and stores this Data (including Personal Data) in order to provide the Software and Services to you, including: (a) maintaining your account and its personalized features and account information; and (b) providing the interactive and customized experiences while you are using the Software.

§ Company may also use your Data internally to improve the Software and Services along with other Company products and services. When we use the Data in this manner, we do not disclose it to third parties, use it for marketing or promotional purposes, or use it to contact you unless it is to contact you about your account for the Software and Services.

§ Company may also use your Data to create de-identified, anonymized, and aggregated data sets. When creating an aggregated data set, Company will strip all personal identifying information from your Data and combine it with other user’s de-identified data and other types of data to create large, aggregated sets of anonymized data. Company uses these aggregated data sets for its own business purposes or provide these aggregated data sets to third parties for their legitimate business purposes, including research and analytical purposes. Company will NEVER include any of your Personal Data or any personally identifiable information in these aggregated data sets. All Data included in an aggregated data set will have all personal identifiers removed so that it is completely de-identified, and then it will be aggregated with other Data so that it is completely anonymized and will not include any data or information that is personal to you or that can be traced to you in any respect.

1. DEFINITIONS

In addition to the terms defined elsewhere in this EULA, the following capitalized and underlined terms shall have the meaning set forth in this Section for purposes of this EULA:

“Access Credentials” shall mean a user name, user date of birth information, identification number (including, but not limited to, a patient identification number and a specimen identification number), password, license or security key, security token, PIN or other security code, method, technology or device used, alone or in combination, to verify an individual’s identity and authorization to access and use the Platform or Services that may be provided to Customer and its Authorized Users by Company.

“Authorized Users” shall mean any employees or agents authorized by Customer to access the Platform or use the Services provided by the Company.

“Company Materials” shall mean the Software, any manuals, instructions, documentation, data or other information provided in connection with the Software and Services, all content and data made available through the Software and Services, all technologies, developments, materials and inventions associated with the Software and Services, and all plans, reports, metrics, data and information provided or used by Company in connection with the Software and Services.

“Data” shall mean all data, measurements, numbers, statistics, figures, calculations, signals and all other information collected, received, compiled, derived, or generated in connection with the use of the Software, including but not limited to, genetic data, medication data, blood pressure data, heart rate data, respiratory and/or breathing pattern data, skin conductance and/or skin temperature data, and other performance data, age, gender, height, weight, geographical location (ZIP code), session dates, and all other information collected and generated in connection with the use of the Software and Services. Data shall also include any information provided by Customer to Company in connection with Customer’s use of the Software and Services, including but not limited to, name, address, email, phone number, and Access Credentials. Data shall not be considered Confidential Information.

“Hardware” shall mean the third-party hardware products, devices and other accessories that are used by Customer to access, and/or use the Software, all of which are owned by third parties and not Company. The Hardware does not include the Software or any Company Materials.

“Order Form” shall mean any agreement providing access to the Company Materials and the Services executed by (a) Company and Customer or (b) Customer and a third party.

“Personal Data” shall mean any Data that constitutes personally identifiable information, including a Customer’s an Authorized User’s name, address, email, telephone number, and Access Credentials.

“Services” shall mean the provision of and making available for access by Customer the Software, along with the features, functionality and services available through the Software.

“Software” shall mean the MedTrait® platform that Company makes available to subscribers and all items of documentation relating to the Software provided by Company, along with any updates, fixes or modifications provided by Company.

2. SOFTWARE AND SERVICES

2.1 License to Software. Through Customer’s use of the Software, Customer is acquiring, and Company grants to Customer, a personal, limited, non-exclusive, non-sublicensable, non-transferable license to use the Software only for use related to Customer’s provision of healthcare related services to its patients and in accordance with the terms and conditions of this EULA.

2.2 Authorization to Use Services. Subject to and conditioned on Customer’s compliance and performance in accordance with the terms and conditions of this EULA, Company hereby authorizes Customer and Customer’s Authorized Users to access and use the Services Company supplies or makes available to Customer, through the use of Customer’s or Authorized Users’ Access Credentials. This authorization is non-exclusive and non-transferable. Customer will be responsible for any loss, theft or misuse of its or its Authorized Users’ Access Credentials.

2.3 Access to Services. Subject to and conditioned on Customer’s compliance with the terms and conditions of this EULA, during the Term, Company will provide Customer with the Services in accordance with the terms and conditions hereof, except for during periods of: (a) scheduled system back-up or other on-going maintenance as required and scheduled in advance; (b) unscheduled maintenance or repairs due to unexpected unavailability or disruption to the Services; (c) any disruption due to force majeure or to which is beyond Company’s reasonable control, including excessive internet traffic, internet outages, unavailability of hosting services and failure of internet service providers; (d) Customer’s misuse of the Services, or use of the Services other than in compliance with the express terms and conditions of this EULA; or (e) any suspension or termination of Customer’s access to or use of the Services as permitted by this EULA.

2.4 Use Restrictions. Customer’s use, access and license to the Software and the Services is limited to Customer individually and Customer’s Authorized Users, and Customer shall be prohibited from authorizing any third party or person from using and/or accessing the Software and the Services through Customer’s or an Authorized User’s Access Credentials. In addition, Customer shall not, nor shall Customer permit any other person to, do any of the following: (a) use the Company Materials and Services for any purpose, or in any manner not specifically authorized by this EULA; (b) copy, distribute or otherwise transfer the Company Materials to any third party; (c) rent, lease, lend, sell, sublicense, assign, distribute, publish, or otherwise make available any of the Company Materials or Services to any person, including on or in connection with the internet or any time-sharing, service bureau, software as a service, cloud or other technology or service; (d) modify, adapt, alter, translate, or create derivative works of the Company Materials; (e) decompile, disassemble, reverse engineer or otherwise derive source code, or attempt to derive source code, from the Company Materials; (f) refer to or otherwise use the Company Materials as part of any effort to develop a program to compete with Company or any other purpose that is to Company’s detriment or commercial disadvantage; (g) remove, delete, alter or obscure any trademarks, documentation, warranties or disclaimers, or any copyright, trademark, patent or other intellectual property or proprietary rights notices from the Company Materials; (h) bypass or breach any security device or protection used by any of the Company Materials or access or use the Company Materials other than through the use of Customer’s own then valid access credentials; (i) input, upload, transmit or otherwise provide to or through Company’s computer or network infrastructure or the Software, any information or materials that are unlawful or injurious, or contain, transmit or activate any harmful code; (j) damage, destroy, disrupt, disable, impair, interfere with or otherwise impede or harm in any manner the Services, the Software, Company’s computer or network infrastructure or Company’s provision of services to any third party, in whole or in part; or (k) use the Software or Services in a manner that violates any international, federal, state, or local law or regulation relating to individual privacy, including, without limitation, the federal Health Insurance Portability and Accountability Act of 1996 and its implementing regulations (45 C.F.R. §§160‒164) (“HIPAA”).

2.5 Changes to Company Materials and Services. Company reserves the right, in its sole discretion, to make any changes to the Company Materials and Services (including the Software) (a) that Company deems necessary or useful to maintain or enhance the quality, delivery, competitive strength, efficiency and performance of the Company Materials and Services, (b) to comply with applicable laws or (c) for any other legitimate business purpose.

3. PROPRIETARY RIGHTS

3.1 Company Materials and Services. All right title and interest in and to all registered and unregistered rights granted, applied for or otherwise now or hereafter in existence under or related to any patent, copyright, trademark, trade secret, database protection or other intellectual property rights laws, and all similar or equivalent rights or forms of protection, in any part of the world (the “Intellectual Property Rights”) in the Software, Services and Company Materials, including any third party materials (but excluding for the avoidance of doubt, personal data) belong solely and exclusively to Company or its suppliers or licensors. Customer acknowledges that the Software (including all methods, concepts or techniques utilized therein) and related documentation are commercially valuable to Company and are treated as confidential, proprietary and containing of trade secrets. All rights not expressly granted to Customer under this EULA are reserved by Company.

3.2 Hardware. All right title and interest in and to the Hardware and any associated Intellectual Property Rights therein belong to the applicable third-party providers of such Hardware. Company does not manufacture, own or control any Hardware that may be used in connection with the Software and Services, and Customer accepts all risks responsibility with respect to its use of such Hardware. Customer shall use the Hardware in accordance with the terms and conditions provided by the third-party providers of such Hardware.

4. TERM AND TERMINATION

4.1 Term. The term of this EULA will commence on the date on which Customer accepts the EULA (or a document incorporating this EULA by reference) by signature, click-through, or use. Unless terminated earlier as set forth below, the EULA will continue in effect until the end of the applicable license or subscription term stated in the applicable agreement or Order Form signed or otherwise executed by Customer (such period, the “Term”).

4.2 Termination. In addition to any other express termination right set forth elsewhere in this EULA, Company may terminate this EULA immediately, effective on written notice to Customer, if Customer (a) materially breaches any provision of this EULA, including without limitation, any of its obligations under Section 2.4 (Use Restrictions) or (b) materially breaches the terms of any Order Form (including the payment terms thereof) then in effect. In addition, Company may, in its sole discretion, terminate this EULA at any time with thirty (30) days’ written notice of its intention to terminate the EULA for any reason whatsoever, with or without cause.

4.3 Survival. The terms and conditions in this EULA, which by their nature and context, are intended to survive any termination, shall so survive such termination. Without limiting the foregoing, surviving provisions shall include those set forth in Sections 1, 2.4, 3, 4, 5.3, 6, 7, 8, 9, and 10 of this EULA.

5. CONFIDENTIALITY

5.1 Restrictions on Disclosure. Customer agrees that during the Term, any renewal term, and at all times thereafter, it will not disclose Company’s Confidential Information (defined below) to any person or entity or third party. Customer will not use any of Company’s Confidential Information for purposes other than in direct connection with Customer’s use of the Software and Services and in the performance of Customer’s obligations under this EULA. Customer will use at least the same degree of care in safeguarding the Company’s Confidential Information as it uses in safeguarding Customer’s own confidential information, but in no event will Customer use less than commercially prudent diligence and care. To the extent Customer is required by subpoena or otherwise by law to disclose Company’s Confidential Information, Customer shall provide Company with prompt written notice of such requirement and shall cooperate with Company in taking such steps as may be reasonably indicated to maintain the confidentiality of the information subject to disclosure. Upon termination of this EULA, Customer will cease using the Company’s Confidential Information for any purpose and, unless otherwise instructed by Company will destroy all documents or other materials in Customer’s possession that contain the Company’s Confidential Information in whatever format, whether written or electronic, including any and all copies or reproductions of the Company’s Confidential Information.

5.2 Confidential Information Defined. As used herein, the term “Confidential Information” shall mean all information and documentation relating directly or indirectly to the Software and Services or Company’s business, business practices, trade secrets or affairs, including but not limited to, information that (a) is marked “Confidential”, “Restricted,” or “Proprietary Information” or other similar marking; (b) pertains to the internal business, financial and marketing information of Company; (c) pertains to the contractual terms, fees and pricing relating to this EULA; (d) pertains to the Software and Services or any software, firmware, and all technology, training content, and know-how associated with the Software, the Services or Company Materials provided to Customer hereunder; (e) is known by the parties to be considered confidential or proprietary; or (f) should be known or understood to be confidential or proprietary by an individual exercising reasonable commercial judgment in the circumstances.

5.3 Exclusions from Confidential Information. Confidential Information does not include information to the extent that such information: (a) is or becomes generally known to the public by any means other than a breach of the obligations of Customer hereunder; (b) was previously known to Customer as evidenced by its written records; (c) is rightly received by Customer from a third party who is not under an obligation of confidentiality; or (d) is independently developed by Customer without reference to or use of Company’s Confidential Information.

6. REPRESENTATIONS AND WARRANTIES

6.1 Mutual Representations and Warranties. The parties each represent, warrant and covenant to the other that such party has the full power and authority to execute, deliver and perform this EULA and to carry out the transactions contemplated hereby.

6.2 Customer Representations and Warranties. Customer further represents and warrants that: (a) the execution, delivery and performance by such party of this EULA does not and will not materially conflict with any legal, contractual, or organizational requirement of Customer; (b) Customer has all necessary rights and licenses to the Hardware not provided by Company that Customer uses in connection with the Software and Services; (c) Customer will not authorize any third party or person to use and/or access the Software and the Services through Customer’s or Authorized Users’ Access Credentials; (d) Customer’s use of the Software and Services will be in compliance with all applicable federal, state and local laws and regulations; and (e) Customer will comply with all other obligations and restrictions with respect to the use of the Software and Services as set forth herein.

6.3 DISCLAIMER. EXCEPT FOR THE WARRANTIES EXPRESSLY SET FORTH IN THIS EULA AND TO THE GREATEST EXTENT ALLOWED BY LAW, COMPANY HEREBY EXPRESSLY DISCLAIMS ALL WARRANTIES AND CONDITIONS, EITHER EXPRESS OR IMPLIED, WITH RESPECT TO THE SOFTWARE, SERVICES AND COMPANY MATERIALS PROVIDED HEREUNDER, INCLUDING BUT NOT LIMITED TO ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR ANY PARTICULAR USE OR PURPOSE, NON-INFRINGEMENT OR MISAPPROPRIATION OF THIRD PARTY RIGHTS OR ANY OTHER MATTER. UNLESS OTHERWISE EXPRESSLY SET FORTH HEREIN, COMPANY MAKES NO WARRANTY OF ANY KIND THAT THE SOFTWARE OR RESULTS OF THE USE THEREOF WILL MEET RESELLER’S OR ANY OTHER PERSON’S REQUIREMENTS, OPERATE WITHOUT INTERRUPTION, ACHIEVE ANY INTENDED RESULT, BE COMPATIBLE OR WORK WITH ANY SOFTWARE, SYSTEM OR OTHER SERVICES, OR BE SECURE, ACCURATE, COMPLETE, FREE OF HARMFUL CODE, OR ERROR-FREE. THE WARRANTIES CONTAINED HEREIN SET FORTH CUSTOMER’S SOLE AND EXCLUSIVE REMEDY IN THE EVENT OF A DEFECT IN WORKMANSHIP OR MATERIALS AND WILL NOT BE DEEMED TO HAVE FAILED ITS ESSENTIAL PURPOSE SO LONG AS COMPANY IS WILLING AND ABLE TO CARRY OUT THE TERMS OF THIS EXCLUSIVE WARRANTY.

6.4 MEDICAL DISCLAIMER. CUSTOMER UNDERSTANDS AND AGREES THAT COMPANY IS NOT ENGAGED IN THE PRACTICE OF MEDICINE AND THE SOFTWARE IS AN INFORMATIONAL TOOL ONLY. THE SOFTWARE IS NOT A SUBSTITUTE FOR THE INDEPENDENT PROFESSIONAL JUDGMENT OF A LICENSED PHYSICIAN OR OTHER HEALTHCARE PROVIDER IN MAKING DIAGNOSES AND CARE DECISIONS FOR PATIENTS. CUSTOMER ACKNOWLEDGES THAT IT OR ITS CLIENTS, AGENTS, AND/OR CONTRACTORS SHALL HAVE COMPLETE RESPONSIBILITY FOR THE CARE OF PATIENTS, AND ANY RELIANCE BY ANY OF THE FORGOING UPON THE SOFTWARE AND THE INFORMATION CONTAINED IN, OR OUT PUT BY, THE SOFTWARE SHALL NOT DIMINISH OR CHANGE SUCH SOLE RESPONSIBILITY AND LIABILITY. CUSTOMER REPRESENTS AND WARRANTS THAT IT HAS REVIEWED AND TESTED THE SOFTWARE AND INDEPENDENTLY DETERMINED THAT THE SOFTWARE IS SUITABLE FOR USE BY CUSTOMER AND/OR ITS CLIENTS, AGENTS, AND/OR CONTRACTORS WHO ARE LICENSED HEALTHCARE PROVIDERS. CUSTOMER ACKNOWLEDGES THAT THE SOFTWARE: (A) IS DEPENDENT UPON THE QUALITY AND QUANTITY OF AVAILABLE DATA; (B) IS INTENDED TO BE A SUPPLEMENTAL TOOL TO LICENSED HEALTHCARE PROVIDERS, AND IS NOT TO BE REGARDED AS DEFINITIVE, COMPLETE, OR HAVING FACTORED IN ALL PATIENT-SPECIFIC QUALITIES AND CIRCUMSTANCES; AND (C) IS NOT, AND SHALL NOT BE CONSIDERED TO BE, A CLINICAL DIAGNOSIS OR RECOMMENDATION.

7. INDEMNIFICATION

Customer will indemnify, defend and hold harmless Company against any loss, damage or expense (including reasonable attorneys’ fees) incurred by Company as a result of claims, actions, or proceedings brought by any third party arising from (a) the use of the Software and Services or any component thereof beyond the scope of permitted use set forth herein or for purposes for which it is not intended, (b) a breach or alleged breach of any representation or warranty of Customer under this EULA, or (c) injury to person or property arising from acts of negligence, bad faith, willful misconduct or reckless disregard by Customer relating to this EULA, provided that Company will have the right, at its option, to defend itself against any such third-party claim or to participate in the defense thereof by counsel of its own choice.

8. Limitation of Liability

COMPANY WILL NOT BE LIABLE FOR ANY SPECIAL, INDIRECT, INCIDENTAL, EXEMPLARY, PUNITIVE OR CONSEQUENTIAL DAMAGES, INCLUDING LOST PROFITS, LOST REVENUE, LOST DATA, REPLACEMENT GOODS, OR INTERRUPTION OF USE OF THE SOFTWARE AND SERVICES, WHETHER IN CONTRACT, TORT, NEGLIGENCE OR OTHERWISE, EVEN IF COMPANY HAS BEEN ADVISED OF THE POSSIBILITY THEREOF. UNDER NO CIRCUMSTANCES WILL COMPANY AGGREGATE LIABILITY TO CUSTOMER FOR ANY LOSSES, CLAIMS, BREACHES OR DAMAGES UNDER THIS EULA EXCEED THE TOTAL AMOUNT RECEIVED BY COMPANY FROM CUSTOMER UNDER THE EULA DURING THE TWELVE (12) MONTHS PRIOR TO THE DATE ON WHICH THE LIABILITY AROSE. THE LIMITATIONS ON DAMAGES IN THIS PARAGRAPH WILL APPLY UNDER ALL THEORIES OF LIABILITY OR CAUSES OF ACTION, INCLUDING CONTRACT, WARRANTY (INCLUDING WARRANTY REMEDIES UNDER THE WARRANTY PARAGRAPH ABOVE), TORT OR STRICT LIABILITY. THE ABOVE LIMITATIONS WILL INURE TO THE BENEFIT OF COMPANY’S SUPPLIERS, AGENTS AND SUBCONTRACTORS.

9. Miscellaneous Provisions

9.1 Excusable Delays in Performance. Company shall not be liable You for any delay in the performance of its obligations hereunder which is unavoidable with reasonable diligence, which occurs without its fault or negligence, and which is caused by an event, act of God, or third party not within Company’s reasonable control; provided.

9.2 Assignment and Subcontracting. Customer may not assign this EULA or any of the rights or obligations hereunder without the prior written consent of Company. Company may freely assign this EULA or any of the rights or obligations hereunder. Company may subcontract work to be performed under this EULA.

9.3 Disputes and Choice of Law. This EULA shall be construed in accordance with Missouri law without giving effect to the choice or conflicts of law provisions thereof. The parties agree that any legal proceedings which arise under this EULA shall be brought in the 21st Judicial Circuit Court in St. Louis County, Missouri USA.

9.4 Miscellaneous Terms. The section headings contained in this EULA are inserted for reference purposes only and will not affect the meaning or interpretation of this EULA. The invalidity or unenforceability of any provision of this EULA will not affect the validity or enforceability of any other provision of this EULA. This EULA constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior negotiations, discussions or representations, whether written or oral. The failure of either party to assert any of its rights under this EULA, including the right to terminate this EULA in the event of a breach or default by the other party, will not be deemed to constitute a waiver by that party of its right thereafter to enforce each and every provision of this EULA in accordance with their terms. The parties to this EULA are independent contractors and this EULA will not establish any relationship of partnership, joint venture, employment, franchise or agency between Company and Customer. Neither party has the power to bind the other or incur obligations on the other’s behalf without the other’s prior written consent, except as otherwise expressly provided herein.

BY CLICKING-THROUGH THIS EULA OR OTHERWISE AGREEING BY USE, CUSTOMER HEREBY AGREES THAT IT HAS REVIEWED, UNDERSTANDS, AND AGREES TO THE TERMS AND CONDITIONS OF THIS EULA, AND FURTHER AGREES TO ENSURE THAT EACH OF CUSTOMER’S EMPLOYEES AND OTHER END USERS DO THE SAME.

LEGAL INFORMATION

This genetic test and the reporting of clinical implications associated with specific genetic findings are intended to provide supplemental information to the healthcare provider in identifying the medication therapy best suited to each individual patient. This report does not constitute medical advice. The genetic test and reported clinical implications are intended to complement, not replace, clinical observations and other information used by the healthcare provider in determining the best medication treatment plan for the patient. The patient’s healthcare provider is responsible for providing medical advice and for making clinical decisions about medication management and treatment for the patient. As medical advice must be tailored to the specific circumstances of each patient, the treating healthcare provider has ultimate responsibility and Trait Technologies, Inc. disclaims any responsibility for treatment decisions made with regard to the patient, including any treatment decisions that take into account the patient’s genotype or other information provided in this report.

Information such as drug interaction dynamics, the impact of lifestyle factors, and duplicate therapy are derived from the Wolters Kluwer Medi-Span drug databases. Wolters Kluwer is solely responsible for the accuracy and completeness of their data. This data will change as new medications enter the market and current drug information is updated. While we believe this report is based on comprehensive current scientific information, it is possible that not all relevant published scientific information has been included in this report and Trait Technologies, Inc. disclaims responsibility for any omissions.

The individual alerts that are taken into consideration in the overall alert score include drug interactions for adverse drug reactions (0-5) and reduced efficacy (0-5), inherent drug risk of the target medication (0-5), and genetic interactions for adverse drug reactions (0-5) and non-efficacy (0-5). Individual alerts are rated on a scale of 0-5, where 0 represents no identified adverse drug reactions or efficacy issues, and 5 equals some risk of serious injury or death. There is a maximum combined alert score of 25. The inherent drug risk of the target medication alone is established based on a number of factors, including the frequency of monitoring necessary for the use of each medication. While use of required monitoring frequency is one indication of risk, it can sometimes cause the inherent risk to be somewhat overstated or understated. Lifestyle factors and duplicate therapy risk are not considered in calculating the overall drug risk, but information currently available about each may be provided in the report.

Potential alternative medications may be listed for medications provided that the total alert score for the alternative medication is less than the current medication. If the information provided to Trait Technologies, Inc. does not indicate the medical condition that the current medication has been prescribed to address, alternative medications are identified in the same medication class for one of the most common uses of the medication, as denoted in the alternatives section. In some cases it will not be possible to identify a lower adverse drug reaction or non-efficacy medication in the same medication class.

These interpretations, including genetic risk factors and the clinical implications associated with specific genetic findings, are based upon data available in the scientific literature and prescribing information for the relevant drugs. Scientifically supported information about genetics and medications is updated over time. This report provides information based on the data available at the time of reporting, but may change in the future due to new discoveries and research. Apart from the medications and genetic factors considered in the MedTrait® Provider Tool, the coadministration of other drugs that inhibit or induce the CYP enzymes, and other genetic and nongenetic factors may alter the efficacy or toxicity of medications mentioned in this report.

Inclusion of any medication trade name in this report is not an indication of endorsement for a specific manufacturer or formulation of a medication. Commonly used trade names of medications may be provided in this report for reference. The names of medications provided may not represent all possible manufacturers or trade names of the denoted medication. Genetic reference citations and definitions of each risk scale are available upon request through the physician’s portal.

This MedTrait report is provided to you by Trait Technologies, Inc. solely so you can review and evaluate the results of the report. Trait Technologies, Inc. retains all right, title and interest in and to all intellectual property embodied within this report.

By reviewing this MedTrait report, you hereby agree to the terms and conditions of the End User License Agreement provided at medtrait.net/legal. If you do not wish to abide by the terms of End User License Agreement, please return this copy of the report to the report’s provider within twenty-four (24) hours of receiving the report.

CHANGES FROM THE ORIGINAL LABORATORY-ISSUED CLINICAL REPORT

A user-updated MedTrait report is generated by the MedTrait interactive app at medtrait.app and is not a substitute for the original laboratory-issued report. This version of a MedTrait report can be identified by its “User-Updated” cover sheet outlining changes made to the patient’s medication list with the interactive app before exporting.

LEGAL INFORMATION REGARDING THE USER-UPDATED REPORT

This MedTrait report is an amended, user-updated MedTrait report which was generated by the MedTrait interactive app at medtrait.app and is not a substitute for the original laboratory-issued report. This version of this patient's report contains changes made to the patient’s medication list with the interactive app before exporting into it's current form.

The original, laboratory-issued MedTrait report can always be found at medtrait.app after logging in with the patient’s data and clicking Report History > View Original Report.

MedTrait is a product of Trait Technologies, Inc. who is the sole owner of information collected on this site (medtrait.net).

We respect and protect your privacy. Our sites are SSL encrypted and is a safe and secure environment for anyone to visit and browse. We do not sell or share your information with any third parties and we are committed to protecting your rights as a consumer.

Trait Technologies, Inc. will not sell, share, or rent this information to any outside parties, except for the sharing of addresses for shipping purposes to shipping vendors. We collect information from our customers to process orders and better serve you with pertinent information, such as order confirmations and order status updates. Information collected includes your name, shipping address, billing address, telephone numbers, e-mail address, and payment information such as your credit card number. We also require you to submit a username and password of your choice for your future access to your account information. If you elect to receive our newsletter or special promotions, your contact information will be used for the delivery of these items.